The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Regulation of Immune Responses by Prostaglandin E2
Open accessAbstract
PGE2, an essential homeostatic factor, is also a key mediator of immunopathology in chronic infections and cancer. The impact of PGE2 reflects the balance between its cyclooxygenase 2-regulated synthesis and 15-hydroxyprostaglandin dehydrogenase-driven degradation and the pattern of expression of PGE2 receptors. PGE2 enhances its own production but suppresses acute inflammatory mediators, resulting in its predominance at late/chronic stages of immunity. PGE2 supports activation of dendritic cells but suppresses their ability to attract naive, memory, and effector T cells. PGE2 selectively suppresses effector functions of macrophages and neutrophils and the Th1-, CTL-, and NK cell-mediated type 1 immunity, but it promotes Th2, Th17, and regulatory T cell responses. PGE2 modulates chemokine production, inhibiting the attraction of proinflammatory cells while enhancing local accumulation of regulatory T cells cells and myeloid-derived suppressor cells. Targeting the production, degradation, and responsiveness to PGE2 provides tools to modulate the patterns of immunity in a wide range of diseases, from autoimmunity to cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prostaglandins as modulators of immunity
Harris, S. G., Padilla, J., Koumas, L., Ray, D., & Phipps, R. P. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02154-8 · Cited by 1,180
Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J.-I., Cheng, P., Cho, H.-I., Celis, E., Quiceno, D. G., Padhya, T., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100587 · Cited by 1,173
Jonuleit, H., Kühn, U., Müller, G., Steinbrink, K., Paragnik, L., Schmitt, E., Knop, J., & Enk, A. H. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271209 · Cited by 1,163
T-cell priming by type-1and type-2 polarized dendritic cells: the concept of a third signal
Kaliński, P., Hilkens, C. M. U., Wierenga, E. A., & Kapsenberg, M. L. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01547-9 · Cited by 933
Hata, A. N., & Breyer, R. M. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.06.003 · Cited by 840
Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines
Betz, M., & Fox, B. S. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.1.108 · Cited by 821
Prostaglandin E2 synthesis and secretion: The role of PGE2 synthases
Park, J. Y., Pillinger, M. H., & Abramson, S. B. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.01.016 · Cited by 793
Prostaglandin E2 Promotes Tumor Progression by Inducing Myeloid-Derived Suppressor Cells
Sinha, P., Clements, V. K., Fulton, A. M., & Ostrand-Rosenberg, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4174 · Cited by 755
Jung, Y.-J., Isaacs, J. S., Lee, S., Trepel, J., & Neckers, L. (2003) · The FASEB Journal · doi:10.1096/fj.03-0329fje · Cited by 679
Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production.
van der Pouw Kraan, T. C., Boeije, L. C., Smeenk, R. J., Wijdenes, J., & Aarden, L. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.775 · Cited by 666
Kaliński, P., Hilkens, C. M., Snijders, A., Snijdewint, F. G., & Kapsenberg, M. L. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.28 · Cited by 602
Prostaglandin E2 Induces FOXP3 Gene Expression and T Regulatory Cell Function in Human CD4+ T Cells
Baratelli, F., Lin, Y., Zhu, L., Yang, S.-C., Heuzé-Vourc’h, N., Zeng, G., Reckamp, K., Dohadwala, M., Sharma, S., & Dubinett, S. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1483 · Cited by 573
A new view of prostaglandin E regulation of the immune response
Phipps, R. P., Stein, S. H., & Roper, R. L. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90064-z · Cited by 523
Sharma, S., Yang, S.-C., Zhu, L., Reckamp, K., Gardner, B., Baratelli, F., Huang, M., Batra, R. K., & Dubinett, S. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0141 · Cited by 506
Scandella, E., Men, Y., Gillessen, S., Förster, R., & Groettrup, M. (2002) · Blood · doi:10.1182/blood-2001-11-0017 · Cited by 500
Obermajer, N., Muthuswamy, R., Lesnock, J., Edwards, R. P., & Kalinski, P. (2011) · Blood · doi:10.1182/blood-2011-07-365825 · Cited by 497
Self-citationHuang, M., Stolina, M., Sharma, S. P., Mao, J. T., Zhu, L. X., Miller, P. W., Wollman, J. S., Herschman, H. R., & Dubinett, S. M. (1998) · PubMed · Cited by 492
Arginase, Prostaglandins, and Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma
Ochoa, A. C., Zea, A. H., Hernandez, C., & Rodriguez, P. C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2197 · Cited by 489
Boniface, K., Bak-Jensen, K. S., Li, Y., Blumenschein, W. M., McGeachy, M. J., McClanahan, T. K., McKenzie, B. S., Kastelein, R. A., Cua, D. J., & de Waal Malefyt, R. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082293 · Cited by 479
Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes
Snijdewint, F. G., Kaliński, P., Wierenga, E. A., Bos, J. D., & Kapsenberg, M. L. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.12.5321 · Cited by 477
(2003) · PubMed · Cited by 477
Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype.
Honda, A., Sugimoto, Y., Namba, T., Watabe, A., Irie, A., Negishi, M., Narumiya, S., & Ichikawa, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53022-2 · Cited by 472
α-Type-1 Polarized Dendritic Cells
Mailliard, R. B., Wankowicz-Kalinska, A., Cai, Q., Wesa, A., Hilkens, C. M., Kapsenberg, M. L., Kirkwood, J. M., Storkus, W. J., & Kalinski, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1261 · Cited by 470
Self-citationStolina, M., Sharma, S., Lin, Y., Dohadwala, M., Gardner, B., Luo, J., Zhu, L., Kronenberg, M., Miller, P. W., Portanova, J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.361 · Cited by 465
Obermajer, N., Muthuswamy, R., Odunsi, K., Edwards, R. P., & Kalinski, P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2449 · Cited by 464
Self-citationUptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages
Freire-de-Lima, C. G., Nascimento, D. O., Soares, M. B. P., Bozza, P. T., Castro-Faria-Neto, H. C., de Mello, F. G., DosReis, G. A., & Lopes, M. F. (2000) · Nature · doi:10.1038/35003208 · Cited by 455
Mouse interleukin‐12 (IL‐12) p40 homodimer: a potent IL‐12 antagonist
Gillessen, S., Carvajal, D., Ling, P., Podlaski, F. J., Stremlo, D. L., Familletti, P. C., Gubler, U., Presky, D. H., Stern, A. S., & Gately, M. K. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250133 · Cited by 436
Receptors for a growing family of secreted phospholipases A2
Lambeau, G. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01300-0 · Cited by 401
A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation
Braun, D., Longman, R. S., & Albert, M. L. (2005) · Blood · doi:10.1182/blood-2005-03-0979 · Cited by 391
Regan, J. W., Bailey, T. J., Pepperl, D. J., Pierce, K. L., Bogardus, A. M., Donello, J. E., Fairbairn, C. E., Kedzie, K. M., Woodward, D. F., & Gil, D. W. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09674-9 · Cited by 390
COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells
Fujita, M., Kohanbash, G., Fellows-Mayle, W., Hamilton, R. L., Komohara, Y., Decker, S. A., Ohlfest, J. R., & Okada, H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3055 · Cited by 385
Kaliński, P., Schuitemaker, J. H. N., Hilkens, C. M. U., & Kapsenberg, M. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2804 · Cited by 371
Self-citationHeusinkveld, M., de Vos van Steenwijk, P. J., Goedemans, R., Ramwadhdoebe, T. H., Gorter, A., Welters, M. J. P., van Hall, T., & van der Burg, S. H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100889 · Cited by 368
Kaliński, P., Vieira, P. L., Schuitemaker, J. H. N., de Jong, E. C., & Kapsenberg, M. L. (2001) · Blood · doi:10.1182/blood.v97.11.3466 · Cited by 362
Self-citationAronoff, D. M., Canetti, C., & Peters-Golden, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.559 · Cited by 360
Luft, T., Jefford, M., Luetjens, P., Toy, T., Hochrein, H., Masterman, K.-A., Maliszewski, C., Shortman, K., Cebon, J., & Maraskovsky, E. (2002) · Blood · doi:10.1182/blood-2001-12-0360 · Cited by 358
Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype.
Sugimoto, Y., Namba, T., Honda, A., Hayashi, Y., Negishi, M., Ichikawa, A., & Narumiya, S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50448-3 · Cited by 357
Cyclooxygenases, prostanoids, and tumor progression
Wang, M.-T., Honn, K. V., & Nie, D. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9096-5 · Cited by 345
Prostaglandin catabolizing enzymes
Tai, H.-H., Ensor, C. M., Tong, M., Zhou, H., & Yan, F. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00050-3 · Cited by 337
Chemokines in the systemic organization of immunity
Campbell, D. J., Kim, C. H., & Butcher, E. C. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00067.x · Cited by 330
The lung as a privileged site for the beneficial actions of PGE2
Vancheri, C. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.11.001 · Cited by 313
Banerjee, D. K., Dhodapkar, M. V., Matayeva, E., Steinman, R. M., & Dhodapkar, K. M. (2006) · Blood · doi:10.1182/blood-2006-03-011353 · Cited by 311
Fujino, H., West, K. A., & Regan, J. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109440200 · Cited by 310
Fujino, H., Xu, W., & Regan, J. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212665200 · Cited by 305
15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Colorectal Cancer
Backlund, M. G., Mann, J. R., Holla, V. R., Buchanan, F. G., Tai, H.-H., Musiek, E. S., Milne, G. L., Katkuri, S., & DuBois, R. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411221200 · Cited by 301
IL-18–induced CD83+CCR7+NK helper cells
Mailliard, R. B., Alber, S. M., Shen, H., Watkins, S. C., Kirkwood, J. M., Herberman, R. B., & Kalinski, P. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050128 · Cited by 286
Self-citationSheibanie, A. F., Yen, J.-H., Khayrullina, T., Emig, F., Zhang, M., Tuma, R., & Ganea, D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.8138 · Cited by 284
Rieser, C., Böck, G., Klocker, H., Bartsch, G., & Thurnher, M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1603 · Cited by 274
Walker, C., Kristensen, F., Bettens, F., & deWeck, A. L. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.4.1770 · Cited by 267
Mahic, M., Yaqub, S., Johansson, C. C., Taskén, K., & Aandahl, E. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.246 · Cited by 248
The Immunomodulatory Roles of Macrophages at the Maternal—Fetal Interface
Nagamatsu, T., & Schust, D. J. (2010) · Reproductive Sciences · doi:10.1177/1933719109349962 · Cited by 248
Tumor cyclooxygenase 2-dependent suppression of dendritic cell function.
Sharma, S. P., Stolina, M., Yang, S.-C., Baratelli, F. E., Lin, J. F.-H., Atianzar, K., Luo, J., Zhu, L., Lin, Y., Huang, M., et al. (2003) · PubMed · Cited by 232
Prostaglandin E2 and Dexamethasone Inhibit IL-12 Receptor Expression and IL-12 Responsiveness
Wu, C.-Y., Wang, K., McDyer, J. F., & Seder, R. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2723 · Cited by 207
Sombroek, C. C., Stam, A. G. M., Masterson, A. J., Lougheed, S. M., Schakel, M. J. A. G., Meijer, C. J. L. M., Pinedo, H. M., van den Eertwegh, A. J. M., Scheper, R. J., & de Gruijl, T. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4333 · Cited by 205
Thrombospondin 1 Is an Autocrine Negative Regulator of Human Dendritic Cell Activation
Doyen, V., Rubio, M., Braun, D., Nakajima, T., Abe, J., Saito, H., Delespesse, G., & Sarfati, M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030705 · Cited by 198
Cyclooxygenase-2 in synaptic signaling
Yang, H., & Chen, C. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480144 · Cited by 195
Nishigaki, N., Negishi, M., & Ichikawa, A. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09407-6 · Cited by 191
Ring, J., Brockow, K., Ollert, M., & Engst, R. (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.00006.x · Cited by 186
Goto, T., Herberman, R. B., Maluish, A., & Strong, D. M. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.3.1350 · Cited by 177
Salcedo, R., Zhang, X., Young, H. A., Michael, N., Wasserman, K., Ma, W.-H., Martins-Green, M., Murphy, W. J., & Oppenheim, J. J. (2003) · Blood · doi:10.1182/blood-2002-11-3400 · Cited by 175
Khayrullina, T., Yen, J.-H., Jing, H., & Ganea, D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.721 · Cited by 170
Prostaglandin E 2 Suppresses Bacterial Killing in Alveolar Macrophages by Inhibiting NADPH Oxidase
Serezani, C. H., Chung, J., Ballinger, M. N., Moore, B. B., Aronoff, D. M., & Peters-Golden, M. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0153oc · Cited by 166
Abdel-Majid, R. M., & Marshall, J. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.1227 · Cited by 165
PGE2-induced metalloproteinase-9 is essential for dendritic cell migration
Yen, J.-H., Khayrullina, T., & Ganea, D. (2008) · Blood · doi:10.1182/blood-2007-05-090613 · Cited by 163
Ability of Mature Dendritic Cells to Interact with Regulatory T Cells Is Imprinted during Maturation
Muthuswamy, R., Urban, J., Lee, J.-J., Reinhart, T. A., Bartlett, D., & Kalinski, P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6818 · Cited by 162
Self-citationBergmann, C., Strauss, L., Zeidler, R., Lang, S., & Whiteside, T. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0767 · Cited by 153
Yu, Y., & Chadee, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3746 · Cited by 151
Huang, S. K., Fisher, A. S., Scruggs, A. M., White, E. S., Hogaboam, C. M., Richardson, B. C., & Peters-Golden, M. L. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100446 · Cited by 146
van Helden, S. F. G., Krooshoop, D. J. E. B., Broers, K. M., Raymakers, R. A. P., Figdor, C. G., & van Leeuwen, F. N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1567 · Cited by 145
Chemotactic action of prostaglandin E 2 on mouse mast cells acting via the PGE 2 receptor 3
Weller, C. L., Collington, S. J., Hartnell, A., Conroy, D. M., Kaise, T., Barker, J. E., Wilson, M. S., Taylor, G. W., Jose, P. J., & Williams, T. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701700104 · Cited by 140
Prostaglandin E2 Suppresses NK Activity In Vivo and Promotes Postoperative Tumor Metastasis in Rats
Yakar, I., Melamed, R., Shakhar, G., Shakhar, K., Rosenne, E., Abudarham, N., Page, G. G., & Ben‐Eliyahu, S. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.08.017 · Cited by 124
Walker, W., & Rotondo, D. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01810.x · Cited by 121
Soontrapa, K., Honda, T., Sakata, D., Yao, C., Hirata, T., Hori, S., Matsuoka, T., Kita, Y., Shimizu, T., Kabashima, K., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018625108 · Cited by 121
Dual roles of PGE 2 -EP4 signaling in mouse experimental autoimmune encephalomyelitis
Esaki, Y., Li, Y., Sakata, D., Yao, C., Segi‐Nishida, E., Matsuoka, T., Fukuda, K., & Narumiya, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915112107 · Cited by 120
Muthuswamy, R., Mueller-Berghaus, J., Haberkorn, U., Reinhart, T. A., Schadendorf, D., & Kaliński, P. (2010) · Blood · doi:10.1182/blood-2009-12-258038 · Cited by 117
The paradigm of type 1 and type 2 antigen‐presenting cells. Implications for atopic allergy
Kapsenberg, M. L., Hilkens, C. M. U., Wierenga, E. A., & Kaliński, P. (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.00006.x-i2 · Cited by 109
Interactions Between the Immune and Neuroendocrine Systems
Rivest, S. (2010) · Progress in brain research · doi:10.1016/s0079-6123(08)81004-7 · Cited by 108
Yan, M., Myung, S., Fink, S. P., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902367106 · Cited by 102
McIlroy, A., Caron, G., Blanchard, S., Frémaux, I., Duluc, D., Delneste, Y., Chevailler, A., & Jeannin, P. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02326.x · Cited by 98
Gomi, K., Zhu, F., & Marshall, J. S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6545 · Cited by 97
Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells
Nakayama, T., Mutsuga, N., Yao, L., & Tosato, G. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0405226 · Cited by 95
Joshi, P. C., Zhou, X., Cuchens, M. A., & Jones, Q. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.885 · Cited by 94
The stability of 13,14-dihydro-15 keto-PGE2
Fitzpatrick, F. A., Aguirre, R., Pike, J. E., & Lincoln, F. H. (1980) · Prostaglandins · doi:10.1016/0090-6980(80)90126-4 · Cited by 91
Ballinger, M. N., Aronoff, D. M., McMillan, T. R., Cooke, K. R., Olkiewicz, K. M., Toews, G. B., Peters-Golden, M. L., & Moore, B. B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5499 · Cited by 87
Inhibition of human B cell responsiveness by prostaglandin E2.
Simkin, N. J., Jelinek, D. F., & Lipsky, P. E. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.4.1074 · Cited by 85
Formation of Prostaglandins E2 and D2 via the Isoprostane Pathway
Gao, L., Zackert, W. E., Hasford, J. J., Danekis, M. E., Milne, G. L., Remmert, C., Reese, J., Yin, H., Tai, H., Dey, S. K., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303984200 · Cited by 85
Eruslanov, E. B., Kaliberov, S. A., Daurkin, I., Kaliberova, L. N., Buchsbaum, D. J., Vieweg, J., & Kusmartsev, S. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802358 · Cited by 84
Cycloxygenase-2 Inhibition Augments the Efficacy of a Cancer Vaccine
Haas, A. R., Sun, J., Vachani, A., Wallace, A. F., Silverberg, M. B., Kapoor, V., & Albelda, S. Μ. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1178 · Cited by 82
Macrophages programmed by apoptotic cells promote angiogenesis via prostaglandin E 2
Brecht, K., Weigert, A., Hu, J., Popp, R., Fißlthaler, B., Korff, T., Fleming, I., Geißlinger, G., & Brüne, B. (2011) · The FASEB Journal · doi:10.1096/fj.10-179473 · Cited by 81
The modulation of human natural killer cell activity by prostaglandins.
Bankhurst, A. D. (1982) · PubMed · Cited by 81
Recruitment and Activation of Natural Killer Cells In vitro by a Human Dendritic Cell Vaccine
Gustafsson, K. U., Ingelsten, M., Bergqvist, L., Nystrom, J. C., Andersson, B. A., & Karlsson‐Parra, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6494 · Cited by 79
Watchmaker, P. B., Berk, E., Muthuswamy, R., Mailliard, R. B., Urban, J. A., Kirkwood, J. M., & Kaliński, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902062 · Cited by 77
Role of cAMP in regulating cytotoxic T lymphocyte adhesion and motility
Valitutti, S., Dessing, M., & Lanzavecchia, A. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230403 · Cited by 76
Kolenko, V. M., Rayman, P. A., Roy, B., Cathcart, M. K., O’Shea, J. J., Tubbs, R., Rybicki, L., Bukowski, R., & Finke, J. H. (1999) · Blood · doi:10.1182/blood.v93.7.2308 · Cited by 75
Tumor Cell Loaded Type-1 Polarized Dendritic Cells Induce Th1-Mediated Tumor Immunity
Hokey, D. A., Larregina, A. T., Erdös, G., Watkins, S. C., & Falo, L. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1692 · Cited by 74
Stock, A. T., Booth, S., & Cerundolo, V. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20101967 · Cited by 71
Advances in the Biology of Lung Cancer Chemoprevention
Hirsch, F. R., & Lippman, S. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.209 · Cited by 69
Wang, X. S., & Lau, H. Y. A. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.01043.x · Cited by 69
Whittaker, D. S., Bahjat, K. S., Moldawer, L. L., & Clare-Salzler, M. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4298 · Cited by 68
van Elssen, C. H. M. J., Vanderlocht, J., Oth, T., Senden-Gijsbers, B. L. M. G., Germeraad, W. T. V., & Bos, G. M. J. (2011) · Blood · doi:10.1182/blood-2010-09-307835 · Cited by 66
Biodistribution of radiolabelled human dendritic cells injected by various routes
Quillien, V., Moisan, A., Carsin, A., Lesimple, T., Lefeuvre, C. P., Adamski, H., Bertho, N., Devillers, A., Leberre, C., & Toujas, L. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1825-9 · Cited by 65
Baratelli, F. E., Heuzé‐Vourc'h, N., Krysan, K., Dohadwala, M., Riedl, K., Sharma, S. P., & Dubinett, S. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5458 · Cited by 60
Hubbard, L. L. N., Ballinger, M. N., Thomas, P. E., Wilke, C. A., Standiford, T. J., Kobayashi, K. S., Flavell, R. A., & Moore, B. B. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902828 · Cited by 56
Loss of 15-Hydroxyprostaglandin Dehydrogenase Expression Contributes to Bladder Cancer Progression
Tseng-Rogenski, S. S., Gee, J., Ignatoski, K. W., Kunju, L. P., Bucheit, A. D., Kintner, H. J., Morris, D. S., Tallman, C. T., Evron, J. M., Wood, C. G., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090875 · Cited by 55
Tumor cell‐derived prostaglandin E2 inhibits monocyte function by interfering with CCR5 and Mac‐1
Zeidler, R., Csanády, M., Gires, O., Lang, S., Schmitt, B., & Wollenberg, B. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.5.661 · Cited by 54
Durand, E. M., & Zon, L. I. (2010) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32833a888c · Cited by 52
Canetti, C. D. A., Serezani, C. H., Atrasz, R. G., White, E. S., Aronoff, D. M., & Peters-Golden, M. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8350 · Cited by 50
Ng, R. L. X., Bisley, J. L., Gorman, S., Norval, M., & Hart, P. H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001693 · Cited by 50
An essential role of prostaglandin E on mouse mast cell induction
Hu, Z., Asano, K., Seki, H., & Shimamura, T. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.4.2134 · Cited by 48
Mittal, R., González-Gómez, I., Panigrahy, A., Goth, K., Bonnet, R., & Prasadarao, N. V. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20092265 · Cited by 47
Hahn, T., Alvarez, I., Kobie, J. J., Ramanathapuram, L. V., Dial, S. M., Fulton, A. M., Besselsen, D. G., Walker, E., & Akporiaye, E. T. (2005) · International Journal of Cancer · doi:10.1002/ijc.21616 · Cited by 44
Editorial: PGE2-producing MDSC: a role in tumor progression?
Serafini, P. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0510303 · Cited by 40
Monrad, S. U., Kojima, F., Kapoor, M., Kuan, E. L., Sarkar, S., Randolph, G. J., & Crofford, L. J. (2010) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2010.10.003 · Cited by 38
Lim, H. W., Thorbecke, G. J., Baer, R. L., & Gigli, I. (1983) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12522659 · Cited by 36
Förstermann, U., & Neufang, B. (1983) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1983.tb02878.x · Cited by 20
Judson, B. L., Miyaki, A., Kekatpure, V. D., Du, B., Gilleaudeau, P., Sullivan-Whalen, M. M., Mohebati, A., Nair, S. V., Boyle, J. O., Granstein, R. D., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0089 · Cited by 16
Mesri, M., Liversidge, J., & Forrester, J. V. (1996) · Immunology · doi:10.1046/j.1365-2567.1996.d01-671.x · Cited by 12
Cited by
Ayala, A., Muñoz, M. F., & Argüelles, S. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/360438 · Cited by 6,349
Liu, J. Z., van Sommeren, S., Huang, H., Ng, S. C., Alberts, R., Takahashi, A., Ripke, S., Lee, J. C., Jostins, L., Shah, T., et al. (2015) · Nature Genetics · doi:10.1038/ng.3359 · Cited by 2,603
CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
McLane, L. M., Abdel-Hakeem, M. S., & Wherry, E. J. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055318 · Cited by 1,975
Böttcher, J. P., Bonavita, E., Chakravarty, P., Blees, H., Cabeza-Cabrerizo, M., Sammicheli, S., Rogers, N. C., Sahai, E., Zelenay, S., & Reis e Sousa, C. (2018) · Cell · doi:10.1016/j.cell.2018.01.004 · Cited by 1,857
The multifaceted roles of fatty acid synthesis in cancer
Röhrig, F., & Schulze, A. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.89 · Cited by 1,651
Metadata
- Authors
- Kalinski, P.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-01-01
- Volume
- 188
- Issue
- 1
- Pages
- 21-28
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2128149258
- Cited by
- 1,474
- References
- 117
- FWCI
- 45.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.